Search clinical trials for: Dienogest (81150037)

Total 66 results

National Research Centre, Egypt

Completed

Role of Suppression of Endometriosis With Progestins Before IVF-ET

Endometriosis | IVF | Pregnancy Rate | Progestins | GnRH-analogue

Egypt
University of Valencia
Poznan University of Medical Sciences; Hospital Universitario San Juan de Alicante and other collaborators

Recruiting

Effect of Management of the Endometrioma on Ovarian Reserve (IMTERO)

Endometrioma

Poland, Spain
Bayer

Completed

Comparative Study of BAY86-5300 With an Extended Flexible Regimen for Endometriosis

Endometriosis

Japan
University of Sao Paulo

Terminated

Study of the Efficacy of Dienogest in the Treatment of Uterine Leiomyomas When Compared to Desogestrel and Goserelin

Uterine Leiomyoma
University of Cagliari

Unknown

Endometrial Preparation Before Operative Hysteroscopy in Premenopausal Women

Uterine Fibroids
Taipei Veterans General Hospital, Taiwan

Completed

Comparison of the Operation and Medical Treatment of Endometriosis and Adenomyosis

Endometriosis | Adenomyosis

Taiwan
Assiut University

Unknown

Role of Dienogest in the Treatment of Patient With Symptomatic Adenomyosis

Adenomyosis
Indonesia University

Completed

Effects of Sulawesi Propolis Extract on Lesion Growth, Apoptotic and Inflammatory Activity of the Rat Endometriosis Tissue

Endometriosis | Endometriosis; Peritoneum

Indonesia
The University of Hong Kong

Unknown

Comparing the Use of Dienogest and Combined Oral Contraceptive Pills (Microgynon) to Reduce the Risk of Recurrence of Endometriotic Cyst After Conservative Surgery

Endometriosis

Hong Kong
Bayer

Completed

Drug-drug Interaction Between Rifampicin and Progestins/Ethinylestradiol and Midazolam

Biological Availability

Germany
Cairo University

Unknown

Dienogest Versus Luteal Phase Fluoxetine in the Management of Premenstrual Syndrome

Premenstrual Syndrome

Egypt
Sidney Kimmel Cancer Center at Thomas Jefferson...

Recruiting

A Two Step Approach to Allogeneic Hematopoietic Stem Cell Transplantation for Patients With Hematologic Malignancies-Increasing GVT Effects Without Increasing Toxicity

Hematopoietic and Lymphoid Cell Neoplasm

United States
Fred Hutchinson Cancer Center
National Cancer Institute (NCI)

Suspended

211At-BC8-B10 Followed by Donor Stem Cell Transplant in Treating Patients With Relapsed or Refractory High-Risk Acute Leukemia or Myelodysplastic Syndrome

Hematopoietic and Lymphoid Cell Neoplasm | Acute Myeloid Leukemia Arising From Previous Myelodysplastic Syndrome | Chronic Myelomonocytic Leukemia | Recurrent Acute Myeloid Leukemia | Refractory Acute Myeloid Leukemia | Myelodysplastic Syndrome With Excess Blasts | Recurrent Acute Lymphoblastic... and other conditions

United States
Fred Hutchinson Cancer Center
National Heart, Lung, and Blood Institute (NHLBI)

Suspended

Total Body Irradiation and Astatine-211-Labeled BC8-B10 Monoclonal Antibody for the Treatment of Nonmalignant Diseases

Non-Malignant Neoplasm

United States
Sidney Kimmel Cancer Center at Thomas Jefferson...

Active, not recruiting

2-Step Approach to Stem Cell Transplant in Treating Participants With Hematological Malignancies

Hematopoietic and Lymphoid Cell Neoplasm

United States
Sidney Kimmel Cancer Center at Thomas Jefferson...
National Cancer Institute (NCI)

Completed

Reduced-Intensity Conditioning Before Donor Stem Cell Transplant in Treating Patients With High-Risk Hematologic Malignancies

Follicular Lymphoma | Myeloid Leukemia | Polycythemia Vera | Hodgkin Lymphoma | Myelofibrosis | Chronic Myelomonocytic Leukemia | Recurrent Adult Acute Myeloid Leukemia | Chronic Lymphocytic Leukemia | Secondary Acute Myeloid Leukemia | Non-Hodgkin Lymphoma | Myelodysplastic Syndrome | Plasma Cell Myeloma | Refractory... and other conditions

United States

Search clinical trials for: Dienogest (81150037)

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in France

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations